A fusion polypeptide is disclosed, which includes: (a) a mucosa targeting polypeptide (b) a translocating peptide for translocation and (c) a antigenic epitope. In addition, a method for enhancing a stimulation of an immune response using the aforementioned fusion polypeptide is also disclosed.